Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2005-07-04
Original market date: See footnote 1
1997-04-16
Product name:
HYPAQUE-M 76%
DIN:
02180677 Electronic product monograph is not available
Company:
AMERSHAM HEALTH INC
2300 Meadowvale Blvd.
Mississauga
Ontario
Canada
L5N 5P9
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous , Intra-Arterial
Number of active ingredient(s):
2
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
36:68.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V08AA01 DIATRIZOIC ACID
Active ingredient group (AIG) number:See footnote5
0201807001
Active ingredient(s) | Strength |
---|---|
DIATRIZOATE MEGLUMINE | 66 % |
DIATRIZOATE SODIUM | 10 % |